Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis.
Shih-Hsuan ChaoYuh-Lih ChangJiin-Cherng YenHsien-Tzung LiaoTsai-Hung WuChia-Li YuChang-Youh TsaiYueh-Ching ChouPublished in: Experimental hematology & oncology (2020)
RTX is more effective than the treatments without RTX for AIHA and MAHA and is well-tolerated.